Clinical outcomes of Thunder-fire moxibustion with or without Yiqi Wenyang Tincture for cancer-related fatigue: a randomized controlled trial
Supportive Care in Cancer · 2026-12 · 34 (12)
DOI: 10.1007/s00520-026-11461-9 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Supportive Care in Cancer, online erschienen am 16.11.2026. Verfasst von Peng Liu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shenzhen Hospital (Longgang), Beijing University of Chinese Medicine, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Moxibustion, Fatigue, Neoplasms, Drugs, Chinese Herbal. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Guangdong Provincial Administration of Traditional Chinese Medicine, Beijing University of Chinese Medicine Shenzhen Hospital (Longgang), Public Hygiene and Health Commission of Shenzhen Municipality.
Abstract (Originalsprache)
Background
Cancer-related fatigue (CRF) is a debilitating symptom with limited treatment options. This study evaluated whether thunder-fire moxibustion (TFM) combined with Yiqi Wenyang Tincture (YWT) could provide additional benefit for CRF beyond conventional integrative management (control).
Methods
In a three-arm randomized controlled trial, 255 cancer patients were allocated (85 per group) to TFM alone, TFM plus YWT (TFM + YWT), or conventional integrative management (control). The primary outcomes were the Revised Piper Fatigue Scale (PFS-R) total score and EORTC QLQ-C30 global quality-of-life score at week 6.
Results
In conservative intention-to-treat analyses using baseline observation carried forward for five missing week-6 assessments, with ANCOVA adjusted for baseline score and HC3 robust standard errors, TFM + YWT had lower PFS-R scores than TFM alone (adjusted mean difference, −0.459; 95% CI, −0.793 to −0.126; Bonferroni-adjusted p = 0.021) and higher global quality of life (2.552; 0.589 to 4.515; Bonferroni-adjusted p = 0.033). Exploratory outcomes were analyzed in the complete-case set.
Conclusion
TFM, particularly when combined with YWT, may provide incremental clinical benefit for CRF; confirmation in larger trials with matched attention controls and longer follow-up is warranted.
Trial registration
Chinese Clinical Trial Registry, ChiCTR2200063288, and International Traditional Medicine Clinical Trial Registry (ITMCTR), ChiMCTR2200006558; registered on September 3, 2022
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shenzhen Hospital (Longgang), Beijing University of Chinese Medicine, Shenzhen, Guangdong, China.
- The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
- Department of Oncology, Shunde Hospital, Guangzhou University of Chinese Medicine, Foshan, Guangdong, China.
- Preparation Center, Shenzhen Hospital (Longgang), Beijing University of Chinese Medicine, Shenzhen, Guangdong, China.
- Department of Oncology, Shenzhen Hospital (Longgang), Beijing University of Chinese Medicine, Shenzhen, Guangdong, China. 623875730@qq.com.
- The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China. caoyang0342@gzucm.edu.cn.
Förderung
- Guangdong Provincial Administration of Traditional Chinese Medicine
- Beijing University of Chinese Medicine Shenzhen Hospital (Longgang)
- Public Hygiene and Health Commission of Shenzhen Municipality
- Guangzhou Municipal Science and Technology Bureau
- Guangzhou University of Chinese Medicine
Zitieren
APA
Liu, P., Du, X., Li, H., Zhao, J., Zhong, Y., Peng, Z., Zhuang, B., Huang, J., Feng, G., & Cao, Y. (2026). Clinical outcomes of Thunder-fire moxibustion with or without Yiqi Wenyang Tincture for cancer-related fatigue: a randomized controlled trial. Supportive Care in Cancer, 34(12). https://doi.org/10.1007/s00520-026-11461-9
Vancouver
Liu P, Du X, Li H, Zhao J, Zhong Y, Peng Z, et al. Clinical outcomes of Thunder-fire moxibustion with or without Yiqi Wenyang Tincture for cancer-related fatigue: a randomized controlled trial. Supportive Care in Cancer. 2026;34(12). doi:10.1007/s00520-026-11461-9
BibTeX
@article{Liu2026,
author = {Liu, Peng and Du, Xiuting and Li, Hongyu and Zhao, Jinhua and Zhong, Yuantao and Peng, Zhaowen and Zhuang, Biyun and Huang, Jinlan and Feng, Gaofei and Cao, Yang},
title = {Clinical outcomes of Thunder-fire moxibustion with or without Yiqi Wenyang Tincture for cancer-related fatigue: a randomized controlled trial},
journal = {Supportive Care in Cancer},
year = {2026},
volume = {34},
number = {12},
doi = {10.1007/s00520-026-11461-9}
}
EUVIMED